Q81.9 - Epidermolysis bullosa, unspecified
|Short Description:||Epidermolysis bullosa, unspecified|
|Long Description:||Epidermolysis bullosa, unspecified|
|Status:||Valid for Submission|
Table of Contents
Q81.9 is a billable ICD-10 code used to specify a medical diagnosis of epidermolysis bullosa, unspecified. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
Unspecified diagnosis codes like Q81.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Congenital nephrotic syndrome, interstitial lung disease, epidermolysis bullosa syndrome
- Epidermolysis bullosa
- Localized dystrophic epidermolysis bullosa
- Nephrotic syndrome, deafness, pretibial epidermolysis bullosa syndrome
- Pretibial epidermolysis bullosa
- Epidermolysis Bullosa-. group of genetically determined disorders characterized by the blistering of skin and mucosae. there are four major forms: acquired, simple, junctional, and dystrophic. each of the latter three has several varieties.
- Epidermolysis Bullosa Acquisita-. form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. direct immunofluorescence shows immunoglobulin g deposited at the dermo-epidermal junction.
- Epidermolysis Bullosa Dystrophica-. form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. it is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. all forms of dystrophic epidermolysis bullosa result from mutations in collagen type vii, a major component fibrils of basement membrane and epidermis.
- Epidermolysis Bullosa Simplex-. a form of epidermolysis bullosa characterized by serous bullae that heal without scarring. mutations in the genes that encode keratin-5 and keratin-14 have been associated with several subtypes of epidermolysis bullosa simplex.
- Epidermolysis Bullosa, Junctional-. form of epidermolysis bullosa having onset at birth or during the neonatal period and transmitted through autosomal recessive inheritance. it is characterized by generalized blister formation, extensive denudation, and separation and cleavage of the basal cell plasma membranes from the basement membrane.
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Epidermolysis
- - bullosa (congenital) - Q81.9
Present on Admission (POA)
Q81.9 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
|POA Indicator Code||POA Reason for Code||CMS will pay the CC/MCC DRG?|
|Y||Diagnosis was present at time of inpatient admission.||YES|
|N||Diagnosis was not present at time of inpatient admission.||NO|
|U||Documentation insufficient to determine if the condition was present at the time of inpatient admission.||NO|
|W||Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.||YES|
|1||Unreported/Not used - Exempt from POA reporting.||NO|
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|Q81.9||757.39 - Skin anomaly NEC|
|Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.|
Your skin is your body's largest organ. It covers and protects your body. Your skin:
- Holds body fluids in, preventing dehydration
- Keeps harmful microbes out, preventing infections
- Helps you feel things like heat, cold, and pain
- Keeps your body temperature even
- Makes vitamin D when the sun shines on it
Anything that irritates, clogs, or inflames your skin can cause symptoms such as redness, swelling, burning, and itching. Allergies, irritants, your genetic makeup, and certain diseases and immune system problems can cause rashes, hives, and other skin conditions. Many skin problems, such as acne, also affect your appearance.
NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases
[Learn More in MedlinePlus]
Epidermolysis BullosaEpidermolysis bullosa is a group of rare diseases that cause fragile skin that leads to blistering and tearing.
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)